BRITISH SOCIETY FOR CELL BIOLOGY
Financial health, per its FY2024 accounts
The accounts state that total unrestricted reserves stood at £185,220, which is above the trustees' stated policy target of £125,000. The charity reported a net deficit of £10,332 for the year, with unrestricted funds decreasing from £208,242 to £185,220. The trustees confirm the charity can operate for the foreseeable future on a going concern basis.
What the accounts disclose
“The trustees require a level of unrestricted reserves of £125,000 to meet existing and committed expenditure in case income is not received.”
Funders the charity credits
Trustees
- Dr Laura Macheskychair
- Dr Helen Katherine Matthews
- Dr Nathalie Yvonne Micheline Signoret
- Dr Simon John Allison
- Dr Tobias Zech
- Dr Viji Mythily Draviam
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2024 | £126k | £131k |
| 31/12/2023 | £104k | £131k |
| 31/12/2022 | £68k | £136k |
| 31/12/2021 | £61k | £58k |
| 31/12/2020 | £132k | £54k |
Common questions
Is BRITISH SOCIETY FOR CELL BIOLOGY financially healthy?
The accounts state that total unrestricted reserves stood at £185,220, which is above the trustees' stated policy target of £125,000. The charity reported a net deficit of £10,332 for the year, with unrestricted funds decreasing from £208,242 to £185,220. The trustees confirm the charity can operate for the foreseeable future on a going concern basis. Its FY2024 accounts were independently examined.
Who funds BRITISH SOCIETY FOR CELL BIOLOGY?
Funders whose own accounts filings name BRITISH SOCIETY FOR CELL BIOLOGY as a grant recipient include THE COMPANY OF BIOLOGISTS.
Known funders
| Funder | Year | Amount |
|---|---|---|
| THE COMPANY OF BIOLOGISTS | FY2024 | £70k |
| THE COMPANY OF BIOLOGISTS | FY2023 | £70k |